首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1609687

2024-2032 年日本側向層析檢測市場報告（按技術、產品、應用、最終用戶和地區）

Japan Lateral Flow Assay Market Report by Technique, Product, Application, End User, and Region 2024-2032

出版日期: 2024年12月05日 | 出版商:

IMARC | 英文 116 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2023年日本側流檢測市場規模達8.368IMARC Group美元。傳染病的日益流行、對即時檢測(POCT) 解決方案的需求不斷成長、側流檢測技術的快速進步、監管部門批准的不斷增加以及不斷升級的健康舉措和宣傳活動是推動這一技術發展的一些因素。

側流分析 (LFA) 是一種廣泛使用的診斷技術，透過毛細管作用進行操作，可快速檢測生物樣本中的特定分析物。在此測定中，將樣品施加到包含固定捕獲試劑和訊號產生元件的測試條的一端。當樣品穿過試紙條時，它與這些成分相互作用，形成可見的測試線和控制線。 LFA 的主動原理在於其簡單性和快速結果，使其成為即時檢測的理想選擇。分析物的存在由可見線指示，使用戶無需複雜的儀器即可評估結果。 LFA 的應用範圍從傳染病檢測到妊娠診斷，因其方便用戶使用性、快速響應時間以及對不同測試環境的適應性而不斷獲得關注。隨著對可訪問且高效的診斷解決方案的需求持續存在，側向層析檢測的積極部署極大地促進了各種醫療保健環境中快速和即時檢測的發展。

日本側向層析檢測市場趨勢：

日本市場的主要驅動力是日益重視先進的醫療保健解決方案和診斷。 LFA 以其簡單、快速和有效的特點，與日本醫療保健系統對提供及時、可訪問的診斷的關注完美契合。隨著該國面臨人口老化和慢性病增加的問題，快速且有效率的現場檢測變得至關重要，這對 LFA 的日益普及做出了重大貢獻。此外，以 COVID-19 大流行等事件為突出的傳染病的全球影響凸顯了快速、準確的診斷工具的重要性。 LFA 在檢測包括病毒和細菌在內的各種傳染源方面發揮著重要作用，在日本加強診斷能力的努力中越來越受到關注。 LFA 在檢測從病原體到生物標記等一系列分析物方面具有多功能性，使其成為應對公共衛生挑戰的寶貴工具。此外，醫療保健產業對預防保健和早期診斷的傾向進一步推動了 LFA 的市場成長。 LFA 對各種醫療保健環境（包括診所、藥房和偏遠地區）的適應性與日本致力於擴大不同人群獲得醫療保健服務的承諾非常一致。此外，日本政府、研究機構和醫療保健提供者在推動診斷技術方面的合作為 LFA 的採用創造了有利的環境。在人口結構變化和不斷變化的醫療保健優先事項的推動下，日本對快速可靠診斷的需求持續成長，該市場有望持續成長，在提高全國診斷測試的效率和可及性方面發揮著至關重要的作用。

日本側流層析檢測市場區隔：

技術見解：

三明治檢測
競爭性分析
多重檢測分析

產品見解：

試劑盒和試劑
側向層析閱讀器
數位/行動閱讀器
桌上型讀碼器

應用見解：

臨床測試
傳染病檢測
心臟標記測試
懷孕和生育力測試
膽固醇測試/血脂分析
藥物濫用檢測
其他
獸醫診斷
食品安全與環境檢測
藥物開發和品質檢測

最終使用者見解：

醫院和診所
診斷實驗室
居家護理
製藥和生物技術公司
其他

競爭格局：

市場研究報告也對競爭格局進行了全面分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

到目前為止，日本橫流檢測市場的表現如何，未來幾年將如何表現？
COVID-19 對日本橫流檢測市場有何影響？
日本橫流檢測市場在技術上的分化是什麼？
日本橫流檢測市場依產品分類是怎樣的？
日本橫流檢測市場在應用方面的詳細情形如何？
日本側流分析市場在最終用戶方面的詳細情形如何？
日本橫流檢測市場價值鏈的各個階段是什麼？
日本橫流偵測的關鍵促進因素和挑戰是什麼？
日本橫流檢測市場的結構如何？
日本橫流檢測市場的競爭程度如何？

本報告回答的關鍵問題：

到目前為止，日本橫流檢測市場的表現如何，未來幾年將如何表現？
COVID-19 對日本橫流檢測市場有何影響？
日本橫流檢測市場在技術上的分化是什麼？
日本橫流檢測市場依產品分類是怎樣的？
日本橫流檢測市場在應用方面的詳細情形如何？
日本側流分析市場在最終用戶方面的詳細情形如何？
日本橫流檢測市場價值鏈的各個階段是什麼？
日本橫流偵測的關鍵促進因素和挑戰是什麼？
日本橫流檢測市場的結構如何？
日本橫流檢測市場的競爭程度如何？

三明治檢測
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
競爭性分析
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
多重檢測分析
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）

第 7 章：日本側流分析市場 - 細分：依產品分類

試劑盒和試劑
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
側向層析閱讀器
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場區隔
  - 數位/行動閱讀器
  - 桌上型讀碼器
- 市場預測（2024-2032）

第 8 章：日本側向層析檢測市場 - 細分：按應用分類

臨床測試
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場區隔
  - 傳染病檢測
  - 心臟標記測試
  - 懷孕和生育力測試
  - 膽固醇測試/血脂分析
  - 藥物濫用檢測
  - 其他
- 市場預測（2024-2032）
獸醫診斷
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
食品安全與環境檢測
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
藥物開發和品質檢測
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）

第 9 章：日本側流分析市場 - 細分：依最終用戶分類

醫院和診所
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
診斷實驗室
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
居家護理
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
製藥和生物技術公司
- 概述
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）
其他
- 歷史與當前市場趨勢（2018-2023）
- 市場預測（2024-2032）

第 10 章：日本側向層析偵測市場 - 競爭格局

概述
市場結構
市場參與者定位
最佳制勝策略
競爭儀表板
公司評估象限

第 11 章：關鍵參與者簡介

Company A

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company B

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company C

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company D

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

Company E

Business Overview
Product Portfolio
Business Strategies
SWOT Analysis
Major News and Events

第 12 章：日本側向層析檢測市場 - 產業分析

促進因素、限制因素和機會
- 概述
- 促進要素
- 限制
- 機會
波特五力分析
- 概述
- 買家的議價能力
- 供應商的議價能力
- 競爭程度
- 新進入者的威脅
- 替代品的威脅
價值鏈分析

第 13 章：附錄

簡介目錄

Product Code: SR112024A19351

Japan lateral flow assay market size reached US$ 836.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,354.8 Million by 2032, exhibiting a growth rate (CAGR) of 5.50% during 2024-2032. The increasing prevalence of infectious diseases, the growing demand for point-of-care testing (POCT) solutions, the rapid advancements in lateral flow assay technology, the rising regulatory approvals, and the escalating health initiatives and awareness campaigns are some of the factors propelling the market.

Lateral Flow Assay (LFA), a widely used diagnostic technique, operates by capillary action, allowing the rapid detection of specific analytes in biological samples. In this assay, a sample is applied to one end of a test strip containing immobilized capture reagents and signal-generating elements. As the sample migrates across the strip, it interacts with these components, forming visible test and control lines. LFA's active principle lies in its simplicity and quick results, making it ideal for point-of-care testing. The analyte's presence is indicated by a visible line, enabling users to assess results without the need for complex instrumentation. With applications ranging from infectious disease testing to pregnancy diagnostics, LFAs continue to gain prominence due to their user-friendly nature, rapid response times, and adaptability to diverse testing environments. As the demand for accessible and efficient diagnostic solutions persists, the active deployment of lateral flow assays contributes significantly to the evolution of rapid and point-of-care testing in various healthcare settings.

Japan Lateral Flow Assay Market Trends:

The market in Japan is majorly driven by the increasing emphasis on advanced healthcare solutions and diagnostics. LFAs, with their simplicity, speed, and effectiveness, align perfectly with the Japanese healthcare system's focus on providing timely and accessible diagnostics. As the country faces an aging population and an increase in chronic diseases, quick and efficient point-of-care testing becomes paramount, contributing significantly to the growing adoption of LFAs. Furthermore, the global impact of infectious diseases, highlighted by events like the COVID-19 pandemic, has underscored the importance of rapid and accurate diagnostic tools. LFAs, being instrumental in the detection of various infectious agents, including viruses and bacteria, are gaining traction in Japan's efforts to strengthen its diagnostic capabilities. The versatility of LFAs in detecting a range of analytes, from pathogens to biomarkers, positions them as valuable tools in managing public health challenges. Besides, the healthcare sector's inclination toward preventive care and early diagnosis further propels the market growth of LFAs. The adaptability of LFAs to various healthcare settings, including clinics, pharmacies, and remote locations, aligns well with Japan's commitment to expanding access to healthcare services across diverse demographics. Additionally, the collaboration between the Japanese government, research institutions, and healthcare providers in advancing diagnostic technologies creates a conducive environment for the adoption of LFAs. As the demand for rapid and reliable diagnostics continues to rise in Japan, driven by demographic shifts and evolving healthcare priorities, the market is poised for sustained growth, playing a vital role in enhancing the efficiency and accessibility of diagnostic testing throughout the country.

Japan Lateral Flow Assay Market Segmentation:

Technique Insights:

Sandwich Assays
Competitive Assays
Multiplex Detection Assays

Product Insights:

Kits and Reagents
Lateral Flow Readers
Digital/Mobile Readers
Benchtop Readers

Application Insights:

Clinical Testing
Infectious Disease Testing
Cardiac Marker Testing
Pregnancy and Fertility Testing
Cholesterol Testing/Lipid Profile
Drug Abuse Testing
Others
Veterinary Diagnostics
Food Safety and Environment Testing
Drug Development and Quality Testing

End User Insights:

Hospitals and Clinics
Diagnostic Laboratories
Home Care
Pharmaceutical and Biotechnology Companies
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan lateral flow assay market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan lateral flow assay market?
What is the breakup of the Japan lateral flow assay market on the basis of technique?
What is the breakup of the Japan lateral flow assay market on the basis of product?
What is the breakup of the Japan lateral flow assay market on the basis of application?
What is the breakup of the Japan lateral flow assay market on the basis of end user?
What are the various stages in the value chain of the Japan lateral flow assay market?
What are the key driving factors and challenges in the Japan lateral flow assay?
What is the structure of the Japan lateral flow assay market and who are the key players?
What is the degree of competition in the Japan lateral flow assay market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Lateral Flow Assay Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Lateral Flow Assay Market Landscape

5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)

6 Japan Lateral Flow Assay Market - Breakup by Technique

6.1 Sandwich Assays
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2018-2023)
- 6.1.3 Market Forecast (2024-2032)
6.2 Competitive Assays
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2018-2023)
- 6.2.3 Market Forecast (2024-2032)
6.3 Multiplex Detection Assays
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2018-2023)
- 6.3.3 Market Forecast (2024-2032)

7 Japan Lateral Flow Assay Market - Breakup by Product

7.1 Kits and Reagents
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2018-2023)
- 7.1.3 Market Forecast (2024-2032)
7.2 Lateral Flow Readers
- 7.2.1 Overview
- 7.2.3 Historical and Current Market Trends (2018-2023)
- 7.2.3 Market Segmentation
  - 7.2.3.1 Digital/Mobile Readers
  - 7.2.3.2 Benchtop Readers
- 7.2.4 Market Forecast (2024-2032)

8 Japan Lateral Flow Assay Market - Breakup by Application

8.1 Clinical Testing
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2018-2023)
- 8.1.3 Market Segmentation
  - 8.1.3.1 Infectious Disease Testing
  - 8.1.3.2 Cardiac Marker Testing
  - 8.1.3.3 Pregnancy and Fertility Testing
  - 8.1.3.4 Cholesterol Testing/Lipid Profile
  - 8.1.3.5 Drug Abuse Testing
  - 8.1.3.6 Others
- 8.1.4 Market Forecast (2024-2032)
8.2 Veterinary Diagnostics
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2018-2023)
- 8.2.3 Market Forecast (2024-2032)
8.3 Food Safety and Environment Testing
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2018-2023)
- 8.3.3 Market Forecast (2024-2032)
8.4 Drug Development and Quality Testing
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2018-2023)
- 8.4.3 Market Forecast (2024-2032)

9 Japan Lateral Flow Assay Market - Breakup by End User

9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2018-2023)
- 9.1.3 Market Forecast (2024-2032)
9.2 Diagnostic Laboratories
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2018-2023)
- 9.2.3 Market Forecast (2024-2032)
9.3 Home Care
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2018-2023)
- 9.3.3 Market Forecast (2024-2032)
9.4 Pharmaceutical and Biotechnology Companies
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2018-2023)
- 9.4.3 Market Forecast (2024-2032)
9.5 Others
- 9.5.1 Historical and Current Market Trends (2018-2023)
- 9.5.2 Market Forecast (2024-2032)

10 Japan Lateral Flow Assay Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Lateral Flow Assay Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis